sb 203580 has been researched along with salinomycin in 1 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (salinomycin) | Trials (salinomycin) | Recent Studies (post-2010) (salinomycin) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 672 | 30 | 409 |
Protein | Taxonomy | sb 203580 (IC50) | salinomycin (IC50) |
---|---|---|---|
Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 0.24 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahn, SC; Kim, KY; Kim, SH; Kim, YW; Ma, JY; Park, KI; Park, SG; Seo, YK; Yu, SN | 1 |
1 other study(ies) available for sb 203580 and salinomycin
Article | Year |
---|---|
Inhibition of Autophagy Promotes Salinomycin-Induced Apoptosis via Reactive Oxygen Species-Mediated PI3K/AKT/mTOR and ERK/p38 MAPK-Dependent Signaling in Human Prostate Cancer Cells.
Topics: Apoptosis; Autophagy; Cell Proliferation; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Humans; Imidazoles; Male; MAP Kinase Signaling System; Membrane Potential, Mitochondrial; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyrans; Pyridines; Reactive Oxygen Species; TOR Serine-Threonine Kinases | 2017 |